BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 15025853)

  • 1. Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.
    Stinchcomb AL; Valiveti S; Hammell DC; Ramsey DR
    J Pharm Pharmacol; 2004 Mar; 56(3):291-7. PubMed ID: 15025853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
    Järbe TU; Henriksson BG; Ohlin GC
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemical composition of Brazilian marihuana samples and the importance of several constituents to the pharmacological activity of the plant].
    Takahashi RN; Zuardi AW; Karniol IG
    Rev Bras Pesqui Med Biol; 1977 Dec; 10(6):379-85. PubMed ID: 609775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and simple procedure for the determination of cannabinoids in hemp food products by gas chromatography-mass spectrometry.
    Pellegrini M; Marchei E; Pacifici R; Pichini S
    J Pharm Biomed Anal; 2005 Jan; 36(5):939-46. PubMed ID: 15620517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of glucuronides as in vivo liver conjugates of seven cannabinoids and some of their hydroxy and acid metabolites.
    Harvey DJ; Martin BR; Paton WD
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):265-79. PubMed ID: 847285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
    J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
    Hine B; Torrelio M; Gershon S
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.
    Yamaori S; Ebisawa J; Okushima Y; Yamamoto I; Watanabe K
    Life Sci; 2011 Apr; 88(15-16):730-6. PubMed ID: 21356216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
    Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and sensitive determination of Delta(9)-tetrahydrocannabinol, cannabidiol and cannabinol in hair by combined silylation, headspace solid phase microextraction and gas chromatography-mass spectrometry.
    Nadulski T; Pragst F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):78-85. PubMed ID: 16971195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
    Murphy LL; Steger RW; Smith MS; Bartke A
    Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
    Coulter C; Wagner JR
    J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.
    Yamaori S; Kushihara M; Yamamoto I; Watanabe K
    Biochem Pharmacol; 2010 Jun; 79(11):1691-8. PubMed ID: 20117100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weather-induced changes in cannabinoid content of hair].
    Kury M; Skopp G; Mattern R
    Arch Kriminol; 2003; 211(1-2):9-18. PubMed ID: 12635486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and disposition of cannabinoids.
    Chiang CN; Rapaka RS
    NIDA Res Monogr; 1987; 79():173-88. PubMed ID: 2830536
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.
    Lin L; Amaratunga P; Reed J; Huang P; Lemberg BL; Lemberg D
    J Anal Toxicol; 2022 Feb; 46(1):76-88. PubMed ID: 33270860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
    Alozie SO; Martin BR; Harris LS; Dewey WL
    Pharmacol Biochem Behav; 1980 Feb; 12(2):217-21. PubMed ID: 6246544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing human hair for Cannabis. III. rapid screening procedure for the simultaneous identification of delta 9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Cirimele V; Sachs H; Kintz P; Mangin P
    J Anal Toxicol; 1996; 20(1):13-6. PubMed ID: 8837945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
    Dalterio S; Steger R; Mayfield D; Bartke A
    Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.